Navigation Links
Sensus Healthcare Announces its Exhibitor Attendance at the 71st Annual American Academy of Dermatology Meeting
Date:2/22/2013

BOCA RATON, Fla., Feb. 22, 2013 /PRNewswire/ -- Sensus Healthcare is proud to announce their exhibitor participation in the 71st Annual American Academy of Dermatology Meeting in Miami Beach, FL on March 1-5, 2013. Visit booth #2701 to learn more about the advanced SRT-100™ superficial radiotherapy platform, featuring SharpBeam™. The SRT-100 offers unique features and benefits providing Dermatologists a non-invasive option for treating their patients who are diagnosed with skin cancer!

(Logo: http://photos.prnewswire.com/prnh/20130222/FL64841LOGO )

We cordially invite all AAD attendees to visit our booth (#2701) at the upcoming 71st Annual Academy of Dermatology Meeting in Miami Beach, FL and rediscover superficial radiotherapy (SRT). We are proud to feature our SRT-100™ non-invasive treatment system and demonstrate the impact it can have on your practice by providing your patients with a non-invasive treatment option while at the same time increasing your productivity and realizing an excellent ROI! "We are very excited by the feedback we are getting from our Dermatology customers. They are experiencing excellent outcomes as their patients are very happy with the results and they feel their investment in the SRT-100 was well worth it," declared Joe Sardano , President/CEO, Sensus Healthcare.    
See you in Miami!

About Sensus Healthcare:  
Sensus Healthcare is the worldwide leader dedicated to Superficial Radiotherapy Technology (SRT). The featured SRT-100 System is the most advanced non-invasive technology used by Dermatologists and Radiation Oncologists throughout the world in treating Basal Cell (BCC) and Squamus Cell (SCC) Carcinomas. The SRT-100 features SharpBeam technology providing the most accurate and safest treatment possible resulting in proven outcomes. Visit our web site to learn more about Sensus Healthcare…………..Taking new aim at treating skin cancer!  www.sensushealthcare.com 

Media Contact: 
Michelle Verina  
Public Relations  
561-922-5808 Ext. *100  
michelle@sensushealthcare.com  


'/>"/>
SOURCE Sensus Healthcare
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
2. Bayer HealthCares Cotavance® Drug Eluting Balloon With Paccocath® Technology Reduced Five-Year Target Lesion Revascularization Rates by 59 Percent in PAD Patients Compared to Those Treated With Uncoated Balloon
3. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
4. Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
5. Sequenom Announces Participation at the 23rd Annual Piper Jaffray Healthcare Conference
6. SuperNova Diagnostics® to Present at the 23rd Annual Piper Jaffray Healthcare Conference in New York City
7. diaDexus, Inc. to Present at the Canaccord Genuity Healthcare Conference
8. ViroPharma to Participate in Two December Healthcare Investor Conferences
9. Celebrating 65 Years of Providing Superior Healthcare Products, Mission Pharmacal Continues to Thrive
10. Questcor Pharmaceuticals to Present at the Oppenheimer Healthcare Conference on December 13, 2011
11. Uroplasty to Present at the Oppenheimer 22nd Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica ... in people with peritoneal or pleural mesothelioma. Their findings are the subject of a ... , Diagnostic biomarkers are signposts in the blood, lung fluid or tissue of ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... is pleased to announce the launch of their brand, UP4™ Probiotics, into Target ... over 35 years, is proud to add Target to its list of well-respected ...
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
Breaking Biology Technology:
(Date:3/31/2016)... PROVIDENCE, R.I. , March 31, 2016  Genomics ... leadership of founding CEO, Barrett Bready , M.D., ... addition, members of the original technical leadership team, including ... Vice President of Product Development, Steve Nurnberg and Vice ... have returned to the company. Dr. Bready ...
(Date:3/23/2016)... 2016 Einzigartige ... und Stimmerkennung mit Passwörtern     ... MESG ), ein führender Anbieter digitaler Kommunikationsdienste, ... SpeechPro zusammenarbeitet, um erstmals dessen Biometrietechnologie einzusetzen. ... Möglichkeit angeboten, im Rahmen mobiler Apps neben ...
(Date:3/22/2016)... and SANDY, Utah , March ... operates the highest sample volume laboratory in ... and UNIConnect, leaders in clinical sequencing informatics and molecular ... of a project to establish the informatics infrastructure for ... NSO has been contracted by the Ontario Ministry ...
Breaking Biology News(10 mins):